Medicare Enrolled

Dr. Krishna Mylavarapu, M.D

Neurology · Houston, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
13300 HARGRAVE RD STE 500, Houston, TX 77070
2817371141
In practice since 2012 (13 years)
NPI: 1275889198 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Mylavarapu from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Mylavarapu? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Mylavarapu

Dr. Krishna Mylavarapu is a neurology in Houston, TX, with 13 years in practice. Based on federal Medicare data, Dr. Mylavarapu performed 1,861 Medicare services across 1,336 unique beneficiaries.

Between the years covered by Open Payments, Dr. Mylavarapu received a total of $9,491 from 50 pharmaceutical and/or device companies across 525 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Mylavarapu is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 13 years in practice▲ Top 20% volume in TX$ $9,491 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,861
Medicare services
Top 20% in TX for neurology
1,336
Unique beneficiaries
$76
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~143 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Hospital follow-up visit, moderate complexity580$57$108
Hospital follow-up visit, high complexity369$86$154
Measurement of brain wave activity (eeg), in coma or asleep188$41$901
Initial hospital admission, high complexity176$123$298
Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional119$146$439
Initial hospital admission, moderate complexity97$94$204
EEG, extended monitoring90$41$564
Measurement of brain wave activity (eeg), awake and drowsy82$40$640
Office visit, established patient (30-39 min)56$69$196
Measurement of brain wave activity (eeg), 61-119 minutes37$61$846
New patient office visit (45-59 min)29$93$257
Critical care, first 30-74 min26$157$3,512
Office visit, established patient (20-29 min)12$45$139
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$9,491
Total received (2018-2024)
Avg $1,356/year across 7 years
Top 28% in TX for neurology
50
Companies
525
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,470 (99.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$21 (0.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$234
2023
$902
2022
$1,667
2021
$1,386
2020
$1,853
2019
$1,549
2018
$1,900

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$1,470
EMD Serono, Inc.
$974
Novartis Pharmaceuticals Corporation
$939
ABBVIE INC.
$674
Biogen, Inc.
$447
Sunovion Pharmaceuticals Inc.
$427
GENZYME CORPORATION
$343
Alexion Pharmaceuticals, Inc.
$304
Boston Scientific Corporation
$291
Medtronic, Inc.
$261
Supernus Pharmaceuticals, Inc.
$229
Celgene Corporation
$223
Allergan Inc.
$212
AbbVie Inc.
$198
Allergan, Inc.
$190
UCB, Inc.
$186
Acorda Therapeutics, Inc
$151
Genentech USA, Inc.
$143
SK Life Science, Inc.
$137
Eisai Inc.
$123
Bayer HealthCare Pharmaceuticals Inc.
$122
Alnylam Pharmaceuticals Inc.
$120
ACADIA Pharmaceuticals Inc
$114
Genentech, Inc.
$101
Medtronic Vascular, Inc.
$97
Teva Pharmaceuticals USA, Inc.
$95
Amneal Pharmaceuticals LLC
$80
Lundbeck LLC
$72
MITSUBISHI TANABE PHARMA AMERICA, INC.
$70
AstraZeneca Pharmaceuticals LP
$68
LivaNova USA, Inc.
$57
Kyowa Kirin, Inc.
$55
Banner Life Sciences, LLC
$51
Neurocrine Biosciences, Inc.
$48
Greenwich Biosciences, Inc.
$46
Impax Laboratories, Inc.
$43
PFIZER INC.
$42
E.R. Squibb & Sons, L.L.C.
$38
Lilly USA, LLC
$38
ARGENX US, INC.
$28
EISAI INC.
$25
Upsher-Smith Laboratories LLC
$25
Horizon Therapeutics plc
$22
JAZZ PHARMACEUTICALS INC.
$22
Biohaven Pharmaceutical Holding Company Ltd.
$20
Nevro Corp.
$18
Avanir Pharmaceuticals, Inc.
$16
ARBOR PHARMACEUTICALS, INC.
$14
Assertio Therapeutics, Inc.
$12
Corium, LLC
$9
Top 3 companies account for 35.6% of total payments
Associated products mentioned in payments ›
AIMOVIG · AJOVY · AMPYRA · APTIOM · AUBAGIO · AUSTEDO · Activase · Adempas · Adlarity · Aimovig · BAFIERTAM · BOTOX · BOTOX THERAPEUTIC · BRILINTA · Briviact · COPAXONE · DUOPA · EMGALITY · EPIDIOLEX · Epidiolex · Fycompa · GILENYA · Horizant · INBRIJA · INGREZZA · INTELLIS ADAPTIVESTIM · KESIMPTA · KYNMOBI · LEMTRADA · LYRICA · MAVENCLAD · MAYZENT · Mavenclad · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · OCREVUS · ONPATTRO · Omnia · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · RADICAVA · REVEAL LINQ · RYTARY · Rebif · Repatha · Reveal LINQ · SOLIRIS · Soliris · TECFIDERA · TROKENDI XR · TYSABRI · UBRELVY · ULTOMIRIS · UPLIZNA · VNS Therapy · VUMERITY · VYEPTI · VYVGART · Vimpat · WATCHMAN · WaveWriter Alpha Prime 16 · ZEPOSIA · ZIPSOR
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $510 per 100 Medicare services performed
Looking for a neurology in Houston?
Compare neurologys in the Houston area by procedure volume, costs, and industry payment transparency.
Browse neurologys nearby

Geographic Context

Neurologys within 10 mi
362
Per 100K population
7.6
County median income
$73,104
Nearest hospital
HOUSTON METHODIST WILLOWBROOK HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Mylavarapu is a mixed practice specialist, with above-average Medicare volume (top 20% in TX), and low-engagement industry engagement.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Mylavarapu experienced with hospital follow-up visit, moderate complexity?
Based on Medicare claims data, Dr. Mylavarapu performed 580 hospital follow-up visit, moderate complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Mylavarapu receive payments from pharmaceutical companies?
Yes. Dr. Mylavarapu received a total of $9,491 from 50 companies across 525 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Mylavarapu's costs compare to other neurologys in Houston?
Dr. Mylavarapu's average Medicare payment per service is $76. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Mylavarapu) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →